Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 89–89 | Cite as

Bortezomib/thalidomide

Sensory ataxia: case report
Case report
  • 17 Downloads

Reference

  1. Piccolo L, et al. Magnetic resonance imaging evidence of posterior column degeneration in a patient with sensory ganglionopathy following low-dose bortezomib and thalidomide treatment for multiple myeloma. Journal of the Peripheral Nervous System 22 (Suppl. 1): S30, Apr 2017. Available from: URL: http://doi.org/10.1111/jns.12203 [abstract] - ItalyGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations